21 Invest France acquired a majority stake in ProductLife Group (PLG) in January
2019. The group has already completed 4 build-ups in France, in the US, Central
Europe and India, in line with the investment thesis based on the creation of an
international platform with a comprehensive range of expertise. In Q2 2022, PLG has
intensified the roll-out of this strategy with two new acquisitions: Quoretex and
Pharma IT.

PLG is one of the three worldwide specialists providing Regulatory affairs and Pharmacovigilance services to major pharmaceutical companies. With these two new acquisitions, the group now counts 800 employees in 40 countries and generates consolidated sales of €M 67.

PLG is a key player capable of providing tailor-made solutions from the pre-marketing phase of a drug or a medical device to the end of its life cycle, at a global scale.

Quoretex | France & Belgium

Founded in 2018, Quoretex is based in France and in Belgium and specializes in Quality management and Regulatory Compliance consulting. Quoretex has developed a range of leading solutions, aimed at improving the quality practices within the pharmaceutical industry, reducing time to market and limiting production stoppages.
Quoretex is integrated into PLG’s Product Compliance Business Unit, reinforcing the group’s capability to offer the most efficient support to its clients in its key area.

Pharma IT | Denmark

Founded in 2016, Pharma IT is Denmark-based Quality and Regulatory Compliance consulting company with a particular expertise in the implementation of IT systems for pharmaceutical, biotech and medical device players. Thanks to Pharma IT, PLG will strengthen its position in the Nordics, reinforce its IT expertise as well as its innovation capacity, which is a key matter to ensure the group's sustainability in the Life Sciences industry.

Xavier Duburcq, CEO of ProductLife Group, says: “Quoretex and Pharma IT are two renowned players with an outstanding reputation. Their European footprint and expertise will enable PLG to expand its range of Quality and Compliance services and to reinforce our value proposition to our clients worldwide. It also accelerates the digital transformation undertaken a few years ago throughout the group.”

Fabrice Voituron, Managing Partner at 21 Invest France, adds: “ProductLife Group has now been propelled to a new dimension in terms of geography, with a reinforced global presence, and in terms of expertise with a comprehensive array of solutions dedicated to the fast-moving Life sciences industry. Led by its CEO Xavier Duburcq, the group carries out its ambitious buy-and-build plan with the objective to become an undisputed leader worldwide. Additional opportunities are currently at advanced stage.”